Adverum Biotechnologies initiates phase 3 ARTEMIS trial evaluating ixoberogene soroparvovec (Ixo-vec) in patients with wet AMD

Published: 03/04/2025

Adverum Biotechnologies initiates phase 3 ARTEMIS trial evaluating ixoberogene soroparvovec (Ixo-vec) in patients with wet AMD

tags

Latest News

NEWS 03.12.2026

Who Is Dr. Charles Pereyra? The Physician Bringing Regenerative Longevity Medicine to the Mainstream – The UBJ

NEWS 03.12.2026

Allowing Stem Cells Space to Thrive – BIOENGINEER.ORG

NEWS 03.12.2026

Two Live Births Achieved Through Stem Cell Therapy in New Delhi – The News Mill

NEWS 03.12.2026

Hip/Knee Injuries Spike Every Spring & Specialists at Pain Physicians NY Say Regenerative Therapies Can Prevent Surgery – The Desert Sun